TGFB1 and keloid: Clinical studies, including Shome et al. (2018), report significant reductions in keloid size, increased elasticity, and improved appearance, attributed to inhibition of TGF-β1, suppression of fibroblast proliferation, and reduction in angiogenesis (Shome et al., 2018).